HARRISBURG — Patients in Pennsylvania’s medical marijuana program should be able to obtain the drug in dry leaf or flower form for vaporization by sometime this summer, the Wolf administration announced Monday.

Health Secretary Dr. Rachel Levine said she was accepting that and other recommendations made recently by an advisory panel, including the addition of four medical conditions to the list of those qualified to use medical marijuana.

State law prevents dispensaries from selling marijuana that’s designed to be smoked, but consumer advocate Chris Goldstein has said patients who buy the dry leaf product are able to smoke it instead of vaporize it.

Levine said the option of dry leaf or flower form could make the drug cheaper to produce and less expensive for patients.

The Washington, D.C.-based Marijuana Policy Project said the change will help the state’s patients.

“Producers will be able to get medicine into the hands of patients much more quickly and for much lower cost to patients,” said Becky Dansky, the group’s legislative counsel.

The list of qualifying conditions is being expanded to include use in cancer remission therapy and opioid-addiction therapy, or for neurodegenerative and spastic movement disorders.

Two grower-processors are currently providing medical marijuana to nine operating dispensaries, with six more grower-processors and eight more dispensaries poised to come online soon.